IPORC Watch Live IP Direct Tags Schedule Press Release

vaccine

Iranpress: Flu vaccine to be distributed to high-risk individuals: Iranian official

Flu vaccine to be distributed to high-risk individuals: Iranian official

Sunday, 27 September 2020 21:18

Tehran (IP) - Head of the Public Relations and Information Center of Iran's Health Ministry Kianoush Jahanpour said the distribution of the flu vaccine to high-risk individuals has begun.

Iranpress: Novel coronavirus, unprecedented, complicated: official

Novel coronavirus, unprecedented, complicated: official

Sunday, 20 September 2020 13:39

Tehran (IP) - The Head of Pasteur Institute of Iran Alireza Biglari stated that the novel coronavirus is a strange and complicated virus that the world is combating.

Iranpress: Iran, Russia to boost technological cooperation

Iran, Russia to boost technological cooperation

Friday, 18 September 2020 13:12

Tehran (IP) - The Vice President for Science and Technology of the Islamic Republic of Iran Sorena Sattari and the President of the Russian Academy of Sciences Alexander Sergeev emphasized the expansion of technological cooperation.

Iranpress: Oxford vaccine trial facing challenge

Oxford vaccine trial facing challenge

Wednesday, 09 September 2020 14:15

The Oxford coronavirus vaccine trial is facing a "challenge", the UK health secretary, Matt Hancock has admitted after it was put on hold due to a suspected serious adverse reaction in one of the vaccine's volunteers.

Iranpress: 3 knowledge-based companies in Iran has made progress on COVID-19 vaccine: VP

3 knowledge-based companies in Iran has made progress on COVID-19 vaccine: VP

Sunday, 06 September 2020 11:11

Urmia (IP) - Three Iranian knowledge-based companies have made significant progress in the production of a coronavirus vaccine, said Iran’s Vice President for Science and Technology Sorena Sattari.

Iranpress: Russia

Russia's coronavirus vaccine is safe, scientific journal reports

Saturday, 05 September 2020 03:18

Researchers realized that 76 volunteers developed antibodies after 21 days and did not present harmful reactions in over 42 days.

<< < ... 6 7 8 > >>